Skip to content

Intrauterine Injection of Human Chorionic Gonadotropin Before Embryo Transfer in Women With Previous IVF Failure

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02329197
Enrollment
380
Registered
2014-12-31
Start date
2014-10-31
Completion date
2016-03-31
Last updated
2014-12-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility, Invitro Fertilization

Keywords

Infertility, Invitro fertilization

Brief summary

Women with history of previous IVF cycle failure will be subjected to a fresh IVF cycle. At the time they will be undergoing embryo transfer, 50 IU of human chorionic gonadotropins diluted in 0.025ml of tissue culture media will be injected intrauterine by embryo transfer catheter 10 minutes before embryo transfer procedure.

Detailed description

Infertile women with history of previous IVF cycle failure will be subjected top a fresh IVF cycle. Following controlled ovarian hyperstimulation, ovum pick up and at the time they will be undergoing embryo transfer, 50 IU of human chorionic gonadotropins diluted in 0.025ml of tissue culture media will be injected intrauterine by embryo transfer catheter 10 minutes before embryo transfer procedure.

Interventions

intrauterine injection of HCG prior to embryo transfer in an IVF cycle

Sponsors

Mansoura University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
19 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

\- women with previous IVF failure undergoing fresh IVF cycle

Exclusion criteria

* women with hydrosalpinges women with intrauterine lesion like submucous fibroid or polyps

Design outcomes

Primary

MeasureTime frame
Live Birth9 months

Countries

Egypt

Contacts

Primary ContactAhmed Gibreel, MD
ahmedfathgi@yahoo.com002/01004045733

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026